Global Enteric Coated and Controlled Release Tablets and Capsules Market Size, Share and Forecast-2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Enteric Coated and Controlled Release Tablets and Capsules Market Size Analysis

Global Enteric Coated and Controlled Release Tablets and Capsules Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Tablets
    1. By Value
    2. Gelatin Coating
      1. Gelatin Coating By Value
    3. Hydroxypropyl Methylcellulose (HPMC) Coating
      1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
  3. Capsules
    1. By Value
    2. Gelatin
      1. Gelatin By Value
    3. Hydroxypropyl Methylcellulose (HPMC)
      1. Hydroxypropyl Methylcellulose (HPMC) By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Antibiotic and Antibacterial Drug
    1. By Value
  3. Vitamins and Dietary Supplement
    1. By Value
  4. Proton Pump Inhibitors
    1. By Value
  5. Anti-Inflammatory Drugs
    1. By Value
  6. Cardiovascular Therapy Drug
    1. By Value
  7. Neurological Drug
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Tablets
    1. By Value
    2. Gelatin Coating
      1. Gelatin Coating By Value
    3. Hydroxypropyl Methylcellulose (HPMC) Coating
      1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
  3. Capsules
    1. By Value
    2. Gelatin
      1. Gelatin By Value
    3. Hydroxypropyl Methylcellulose (HPMC)
      1. Hydroxypropyl Methylcellulose (HPMC) By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Antibiotic and Antibacterial Drug
    1. By Value
  3. Vitamins and Dietary Supplement
    1. By Value
  4. Proton Pump Inhibitors
    1. By Value
  5. Anti-Inflammatory Drugs
    1. By Value
  6. Cardiovascular Therapy Drug
    1. By Value
  7. Neurological Drug
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Tablets
    1. By Value
    2. Gelatin Coating
      1. Gelatin Coating By Value
    3. Hydroxypropyl Methylcellulose (HPMC) Coating
      1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
  3. Capsules
    1. By Value
    2. Gelatin
      1. Gelatin By Value
    3. Hydroxypropyl Methylcellulose (HPMC)
      1. Hydroxypropyl Methylcellulose (HPMC) By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Antibiotic and Antibacterial Drug
    1. By Value
  3. Vitamins and Dietary Supplement
    1. By Value
  4. Proton Pump Inhibitors
    1. By Value
  5. Anti-Inflammatory Drugs
    1. By Value
  6. Cardiovascular Therapy Drug
    1. By Value
  7. Neurological Drug
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Tablets
    1. By Value
    2. Gelatin Coating
      1. Gelatin Coating By Value
    3. Hydroxypropyl Methylcellulose (HPMC) Coating
      1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
  3. Capsules
    1. By Value
    2. Gelatin
      1. Gelatin By Value
    3. Hydroxypropyl Methylcellulose (HPMC)
      1. Hydroxypropyl Methylcellulose (HPMC) By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Antibiotic and Antibacterial Drug
    1. By Value
  3. Vitamins and Dietary Supplement
    1. By Value
  4. Proton Pump Inhibitors
    1. By Value
  5. Anti-Inflammatory Drugs
    1. By Value
  6. Cardiovascular Therapy Drug
    1. By Value
  7. Neurological Drug
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Tablets
  1. By Value
  2. Gelatin Coating
    1. Gelatin Coating By Value
  3. Hydroxypropyl Methylcellulose (HPMC) Coating
    1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
3. Capsules
  1. By Value
  2. Gelatin
    1. Gelatin By Value
  3. Hydroxypropyl Methylcellulose (HPMC)
    1. Hydroxypropyl Methylcellulose (HPMC) By Value
By Application
1. Introduction
  1. Application By Value
2. Antibiotic and Antibacterial Drug
  1. By Value
3. Vitamins and Dietary Supplement
  1. By Value
4. Proton Pump Inhibitors
  1. By Value
5. Anti-Inflammatory Drugs
  1. By Value
6. Cardiovascular Therapy Drug
  1. By Value
7. Neurological Drug
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Tablets
    1. By Value
    2. Gelatin Coating
      1. Gelatin Coating By Value
    3. Hydroxypropyl Methylcellulose (HPMC) Coating
      1. Hydroxypropyl Methylcellulose (HPMC) Coating By Value
  3. Capsules
    1. By Value
    2. Gelatin
      1. Gelatin By Value
    3. Hydroxypropyl Methylcellulose (HPMC)
      1. Hydroxypropyl Methylcellulose (HPMC) By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Antibiotic and Antibacterial Drug
    1. By Value
  3. Vitamins and Dietary Supplement
    1. By Value
  4. Proton Pump Inhibitors
    1. By Value
  5. Anti-Inflammatory Drugs
    1. By Value
  6. Cardiovascular Therapy Drug
    1. By Value
  7. Neurological Drug
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Enteric Coated and Controlled Release Tablets and Capsules Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Lonza
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
CapsulCN International Co., Ltd.
NATURAL CAPSULES LIMITED
CapsCanada
Suheung Co., Ltd.
GFR Pharma, ACG
Shaanxi Genex Bio-Tech Co., Ltd.
GELITA AG
Colorcon and Almac Group

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment